Why Teva Pharmaceutical is an attractive buying opportunity
Posted on November 03, 2012 at 11:26 AM EDT
Teva is an undervalued stock and leader in the generic drugs field. The post Why Teva Pharmaceutical is an attractive buying opportunity appeared first on Smarter Investing . Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model Managers to establish investment models. The commentary here is provided as general and impersonal information and should not be construed as recommendations or advice. Information from Model Managers and third-party sources deemed to be reliable but not guaranteed. Past performance is no guarantee of future results. Transaction histories for Covestor models available upon request. Additional important disclosures available at http://site.covestor.com/help/disclosures. For information about Covestor and its services, go to http://covestor.com or contact Covestor Client Services at (866) 825-3005, x703.